ST3GAL6 Antikörper (C-Term)

Produktnummer ABIN1887120

Produktdetails anti-ST3GAL6 Antikörper

Target: ST3GAL6 (ST3 beta-Galactoside alpha-2,3-Sialyltransferase 6 (ST3GAL6))

Bindungsspezifität: C-Term

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser ST3GAL6 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunocytochemistry (ICC)

Aufreinigung: Affinity chromatography purified via peptide column

Immunogen: 16 amino acid peptide from near the carboxy terminus of human ST3gal6.

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS containing 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.

Handhabung: Avoid freezing and thawing repeatly.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C for short term use.Store at -20 °C for long term preservation.

Details zu ST3GAL6

Target: ST3GAL6 (ST3 beta-Galactoside alpha-2,3-Sialyltransferase 6 (ST3GAL6))

Andere Bezeichnung: ST3gal6 (ST3GAL6 Produkte)

Synonyme: SIAT10 antikoerper, ST3GALVI antikoerper, 1700023B24Rik antikoerper, AI930218 antikoerper, AW552396 antikoerper, Siat10 antikoerper, St3galVI antikoerper, ST3GAL-VI antikoerper, ST3 beta-galactoside alpha-2,3-sialyltransferase 6 antikoerper, ST3GAL6 antikoerper, St3gal6 antikoerper

Hintergrund: Sialyltransferases catalyze the transfer of sialic acid from cytidine 5-prime monophospho-N-acetylneuraminic acid (CMP-NeuAc) to terminal positions of glycoprotein and glycolipid carbohydrate groups.Terminal NeuAc residues are key determinants of carbohydrate structures, such as the sialyl-Lewis X determinants, and are widely distributed in many cell types.However, cancer cells often express more heavily sialylated glycans on their cell surface and this feature sometimes correlates with invasiveness.In contrast, expression of ST3gal6, a member of the sialyltransferase family that sialylates type II lactosamine structures on glycoproteins and glycolipids, was found to be significantly decreased by hypermethylation of the gene in gastrointestinal cancer.At least three isoforms of ST3gal6 are known to exist.
Synonyms: Alpha2, 3-sialyltransferase 6, ST3Gal VI, siat10

NCBI Accession: NP_006091

Pathways: Glycosaminoglycan Metabolic Process